Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
Skip to main content

Healthcare & Pharmaceuticals

FDA classifies Philips ventilator recall as most serious

1 minute read

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo

July 22 (Reuters) - The U.S. Food and Drug Administration on Thursday classified the recall of Philips' (PHG.AS) breathing devices and ventilators as Class 1, or the most serious type of recall, saying the use of these devices may cause serious injuries or death.

The agency said there have been 83 complaints regarding the products used to provide breathing assistance, but no injuries or deaths were reported for these issues.

The Dutch medical equipment company recalled some of its breathing devices and ventilators in June, as the foam used to dampen the machines' sound could degrade and emit small particles that irritate airways. The gases released may also be toxic or carry cancer risks, Philips had said. read more

Reporting by Mrinalika Roy in Bengaluru; Editing by Devika Syamnath

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters